Study of long-term carglumic acid use in organic acidemia
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how people with organic acidemia (like MMA or PA) do over the long term while taking carglumic acid. The research may help improve long-term management and support for patients and caregivers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of organic acidemia (for example, MMA or PA)
- You started taking carglumic acid for long-term treatment of MMA or PA
- You have been taking carglumic acid for at least 6 months
- You (or a caregiver) can follow the study steps as planned
- You (or a legally authorized person) can give informed consent to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at how Carbaglu® is used and how well it works for people with methylmalonic acidemia (MMA) or propionic acidemia (PA). It may help doctors understand real-world care for adults and children living with these conditions.
This is a “chart review” study that looks at how people with propionic acidemia have symptoms and medical events over time. It uses existing medical records (not an experimental drug) to better understand the disease and care needs.
This study follows people with propionic acidemia to better understand how the body, diet, gut bacteria, and blood chemistry change over time. It may help researchers learn more about the condition and how pregnancy, transplant, and daily life affect health.
This trial tests an mRNA medicine (mRNA-3927) in people with propionic acidemia (PA). It aims to see whether this treatment is safe and can help the body when PA is confirmed by genetic testing.
This research study follows patients with methylmalonic acidemia (a rare metabolic disorder affecting how the body breaks down certain proteins) or cobalamin (vitamin B12) disorders to better understand how these conditions develop and progress over time. Researchers will collect medical information, blood samples, and eye exams to help improve future treatments.
This trial tests a new gene therapy treatment designed to help the body process certain amino acids better in infants with propionic acidemia. The therapy uses a modified virus to deliver a working copy of a faulty gene, potentially reducing dangerous acid buildups and hospital visits.
Hear when a new Methylmalonic Acidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.